Profil
Søren Lemonius is currently a Director-Executive Board at Evolva SA, Director at Sunstone LSV General Partner I ApS, Director at Galecto Biotech ApS, Director at Sunstone LSV Special Limited Partner II Aps, Director at P, Director at Sunstone LSV Management A, Director at Sunstone LSV Special LP II Holding Aps, Director at Sunstone LSV Gp I Holding ApS, Director at Sunstone Lsv Partners & Co. Holding ApS, Director at Sunstone Lsv Partners Holding ApS, Director at Sunstone LSV General Partner BI ApS, Director at Sunstone LSV GP BI Holding ApS, Managing Director at Betterinvest ApS, Managing Director at Sunstone LSV & Co. Special Limited Partner III Holding ApS, and Director at Synendos Therapeutics AG.
He previously held positions such as Chairman at Biomonitor ApS, Chairman at TD Vaccines A, Investment Director at Danmarks Eksport- og Investeringsfond, Director at Euro-Diagnostica AB, Director at Atonomics A, Independent Director at Nuevolution AB, Director at Chempaq A, Director at Symphogen A, Director at Evolva Biotech A, Director at Nuevolution A, Managing Director at Sunstone LSV Partners & Co. Holding III ApS, Managing Director at Sunstone LSV Partners Holding III ApS, Managing Director at Sunstone LSV Invest III Holding ApS, Managing Director at Sunstone LSV Invest III ApS, Managing Director at Sunstone LSV Special Limited Partner III Aps, Director at Chempaq Patent Holding ApS, Director at Sunstone Lsv Special Ltd. Partner Iii Holding Aps, and Director at Galecto, Inc. He also worked as an Innovation Manager at Foss Analytical A and as a Chief Technology Officer at Strategic Investments A. Mr. Lemonius received an undergraduate degree from the University of Southern Denmark.
Postes actifs de Søren Lemonius
| Sociétés | Poste | Début |
|---|---|---|
Betterinvest ApS | Directeur Général | - |
Sunstone LSV & Co. Special Limited Partner III Holding ApS | Directeur Général | - |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Directeur/Membre du Conseil | - |
Sunstone LSV General Partner I ApS | Directeur/Membre du Conseil | - |
Sunstone LSV Special Limited Partner II Aps | Directeur/Membre du Conseil | - |
Sunstone LSV Management A/S | Directeur/Membre du Conseil | - |
Sunstone LSV Special LP II Holding Aps | Directeur/Membre du Conseil | - |
Sunstone LSV Gp I Holding ApS | Directeur/Membre du Conseil | - |
Sunstone Lsv Partners & Co. Holding ApS | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Søren Lemonius
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Søren Lemonius
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 38 |
|---|---|
Foss Analytical A/S
Foss Analytical A/S Electronic Equipment/InstrumentsElectronic Technology Manufactures equipment for measuring, testing, navigation and control | Electronic Technology |
Biomonitor ApS
Biomonitor ApS Medical/Nursing ServicesHealth Services Provides bioassays to monitor patients’ response to biological therapeutics | Health Services |
Strategic Investments A/S
Strategic Investments A/S Investment Trusts/Mutual FundsMiscellaneous Engages in the investment on securities and financial instruments | Miscellaneous |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Finance |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Provides autoimmunity testing and diagnostic solutions | Health Technology |
Atonomics A/S
Atonomics A/S Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic equipment for the biotechnology industries | Electronic Technology |
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology Discovers and develops novel vaccines for the prevention and treatment of bacterial infections | Health Technology |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuevolution AB
Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Commercial Services |
Chempaq A/S
Chempaq A/S Medical SpecialtiesHealth Technology Develops and distributes medical devices & technology | Health Technology |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Evolva Biotech A/S | |
Sunstone LSV General Partner I ApS | |
TD Vaccines A/S
TD Vaccines A/S Pharmaceuticals: MajorHealth Technology Provides vaccines to protect against travellers' diarrhoea | Health Technology |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Nuevolution A/S
Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Sunstone LSV Special Limited Partner II Aps | |
Sunstone LSV Management A/S | |
Sunstone LSV Special LP II Holding Aps | |
Sunstone LSV Gp I Holding ApS | |
Sunstone Lsv Partners & Co. Holding ApS | |
Sunstone Lsv Partners Holding ApS | |
Sunstone LSV General Partner BI ApS | |
Sunstone LSV GP BI Holding ApS | |
Sunstone LSV Partners & Co. Holding III ApS | |
Sunstone LSV Partners Holding III ApS | |
Betterinvest ApS | |
Sunstone LSV Invest III Holding ApS | |
Sunstone LSV & Co. Special Limited Partner III Holding ApS | |
Sunstone LSV Invest III ApS | |
Sunstone LSV Special Limited Partner III Aps | |
Chempaq Patent Holding ApS | |
Sunstone Lsv Special Ltd. Partner Iii Holding Aps | |
Sunstone Life Science Ventures A/S
Sunstone Life Science Ventures A/S Financial ConglomeratesFinance Provide investment services | Finance |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Synendos Therapeutics AG
Synendos Therapeutics AG BiotechnologyHealth Technology Operates as a clinical stage and neuroscience company which develops therapies for neuropsychiatric disorders | Health Technology |
















